SCHEMBL30765771

SCHEMBL30765771

COC(=O)Cn1c(-c2ccc(O[C@@H]3CO[C@H]4[C@@H]3OC[C@H]4OC)cc2)ncc(N)c1=O

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ELANE P08246 16/20 0.44
CMA1 P23946 4/20 0.40
CTRC Q99895 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30765568 0.92 ELANE (0.43) ELANECMA1CTRC
SCHEMBL30765726 0.88 BCHE (0.44) ELANECMA1CTRC
SCHEMBL30765831 0.79 CASP1 (0.40) ELANE
SCHEMBL30765493 0.79 BCHE (0.44) ELANECMA1CTRC
SCHEMBL30765956 0.78 CASP1 (0.41) ELANE
SCHEMBL30765599 0.76 CTRC (0.54) ELANECMA1CTRC
SCHEMBL30765476 0.74 ELANE (0.40) ELANE
SCHEMBL30765978 0.74 ELANE (0.41) ELANECMA1
SCHEMBL30765883 0.67 TDP1 (0.39)
SCHEMBL6804164 0.66 CMA1 (0.48) ELANECMA1CTRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568666-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS Alexion Pharmaceuticals, Inc. (US) 2025-06-18 EP disclosed
WO-2024035686-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2024-02-15 WO disclosed